Viewing Study NCT00992693

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-02-20 @ 6:42 PM
Study NCT ID: NCT00992693
Status: WITHDRAWN
Last Update Posted: 2020-01-02
First Post: 2009-10-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
Sponsor: U.S. Army Medical Research and Development Command
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crimean-Congo Hemorrhagic Fever View
None Lassa Fever View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Crimean-Congo Hemorrhagic Fever View
None Lassa Fever View
None CCHF View
None LF View
None Viral Hemorrhagic Fever View
None VHF View
None Ribavirin View